Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome (2026)
Source: Molecular Therapy - Nucleic Acids. Unidades: ICB, EACH
Subjects: MÚSCULO ESQUELÉTICO, OLIGONUCLEOTÍDEOS, PROTEÍNAS DE LIGAÇÃO DO CÁLCIO, CAMUNDONGOS
ABNT
SANTOS, Audrei dos Reis et al. Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome. Molecular Therapy - Nucleic Acids, v. 37, p. 01-09, 2026Tradução . . Disponível em: http://dx.doi.org/10.1016/j.omtn.2026.102846. Acesso em: 01 maio 2026.APA
Santos, A. dos R., Pereira, M. G., Rozanski, A., Fuziwara, C. S., Nascimento, T. L., Pereira, L. V., et al. (2026). Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome. Molecular Therapy - Nucleic Acids, 37, 01-09. doi:10.1016/j.omtn.2026.102846NLM
Santos A dos R, Pereira MG, Rozanski A, Fuziwara CS, Nascimento TL, Pereira LV, Aoki MS, Miyabara EH. Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome [Internet]. Molecular Therapy - Nucleic Acids. 2026 ; 37 01-09.[citado 2026 maio 01 ] Available from: http://dx.doi.org/10.1016/j.omtn.2026.102846Vancouver
Santos A dos R, Pereira MG, Rozanski A, Fuziwara CS, Nascimento TL, Pereira LV, Aoki MS, Miyabara EH. Downregulation of S100a8 mitigates fibrosis in skeletal muscles affected by Marfan syndrome [Internet]. Molecular Therapy - Nucleic Acids. 2026 ; 37 01-09.[citado 2026 maio 01 ] Available from: http://dx.doi.org/10.1016/j.omtn.2026.102846
